Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Technology Transfer
Qvents Team
1 minute read
Guidelines
Home
Guidelines
Technology Transfer
Updated on May 26, 2025
Home
Guidelines
Technology Transfer
Updated on May 26, 2025
WHO
TRS 1044 – Annex 4
:
WHO Guidelines on Technology Transfer in Pharmaceutical Manufacturing
ISPE
:
Good Practice Guide: Technology Transfer
(3rd Edition)
PDA
Technical Report No.65 Revised 2022 (TR 65) Technology Transfer
IPA
(India): Guidance for Technology Transfer
Share:
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
Unichem Recalls Hypertension Tablets for Nitrosamine Impurity
February 16, 2026
USFDA 483 to Pharmathen Flags Deficient Aseptic Operations
February 5, 2026
Imprimis Recall Unapproved Ophthalmic Injections for Glass Particulates in US
January 5, 2026
Qvents Apps and Tools For QMS and GMP Processes
November 26, 2025
Laboratory Incidents and Validation Failures Lead to USFDA Warning Letter for Cdymax
November 25, 2025
